 REDWOOD CITY, Calif., Sept. 29, 2021 GLOBE NEWSWIRE -- It is with profound sadness that Coherus BioSciences, Inc. Nasdaq: CHRS announces the passing of board member Samuel Nussbaum, M.D. During his distinguished career, Dr. Nussbaum worked as a physician, researcher, professor, and healthcare executive. He had been a director of the Company since May 2018. 